Humasis Co. Ltd. (KOSDAQ:205470)
South Korea
· Delayed Price · Currency is KRW 706.00
-47.00 (-6.24%)
Mar 9, 2026, 3:30 PM KST
Humasis Revenue
Humasis had revenue of 8.65B KRW in the quarter ending September 30, 2025, a decrease of -17.91%. This brings the company's revenue in the last twelve months to 35.60B, up 114.87% year-over-year. In the year 2024, Humasis had annual revenue of 25.41B with 83.79% growth.
Revenue (ttm)
35.60B
Revenue Growth
+114.87%
P/S Ratio
2.24
Revenue / Employee
515.97M
Employees
69
Market Cap
79.89B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,556.97B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| Sam Chun Dang Pharm. | 220.74B |
| GeneOne Life Science | 30.90B |
| Gencurix | 3.39B |
| Enzychem Lifesciences | 72.17B |
| Oncocross | 884.68M |